Phase II study with histone deacetylase (HDAC) inhibitor Valproic acid (VPA) in patients with advanced melanoma

Authors :: Francesco Contegno
G. Zampino
F. Nolè
L. Orlando
Alessandro Testori
A. Bertuzzi
N. Fazio
C. Catania
Elisabetta Munzone
Giulio Tosti
A. Rocca
Giuseppina Sanna
M. Ballarini
S. Minucci
Source :: Melanoma Research. 14:S22-S23
Publication Year :: 2004
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2004.

Subjects :: Cancer Research
Valproic Acid
Oncology
Chemistry
HDAC inhibitor
medicine
Cancer research
Phases of clinical research
In patient
Dermatology
Histone deacetylase
medicine.drug
Advanced melanoma

Full Text Access

Tools